|Bid||9.99 x 1200|
|Ask||11.05 x 1300|
|Day's range||10.42 - 10.94|
|52-week range||3.44 - 24.34|
|Beta (5Y monthly)||1.79|
|PE ratio (TTM)||18.93|
|Earnings date||09 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||26.75|
NEW YORK, October 16, 2021--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Organogenesis Holdings, Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO) on behalf of Organogenesis stockholders. Our investigation concerns whether Organogenesis has violated the federal securities laws and/or engaged in other unlawful business practices.
LOS ANGELES, October 14, 2021--INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Organogenesis Holdings Inc.
LOS ANGELES, October 13, 2021--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Organogenesis Holdings Inc.